| review article | Q7318358 |
| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/gpb/AnG15 |
| P356 | DOI | 10.1016/J.GPB.2015.08.005 |
| P932 | PMC publication ID | 4747650 |
| P698 | PubMed publication ID | 26751805 |
| P5875 | ResearchGate publication ID | 290157009 |
| P2093 | author name string | Youhe Gao | |
| Manxia An | |||
| P2860 | cites work | Discovery and validation of urinary exposure markers for different plant foods by untargeted metabolomics. | Q50464473 |
| 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. | Q50663896 | ||
| Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease. | Q51060069 | ||
| Metabonomic profiling: a novel approach in neuroendocrine neoplasias. | Q51171352 | ||
| Approach to the patient with renal disease. | Q51878834 | ||
| Family history influences age of onset in bipolar I disorder in females but not in males. | Q51980857 | ||
| ¹H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. | Q53446586 | ||
| Traumatic brain injury | Q54273190 | ||
| Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. | Q55067698 | ||
| Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy | Q57712178 | ||
| Searching for biomarkers in neurodegeneration | Q57971994 | ||
| Bipolar disorder | Q77549686 | ||
| A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus | Q82262560 | ||
| 1H-NMR-based metabolomics study of cerebral infarction | Q83809378 | ||
| Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers | Q85214889 | ||
| Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison | Q24676950 | ||
| Metabolomics of human brain aging and age-related neurodegenerative diseases | Q26992344 | ||
| Urine proteins identified by two-dimensional differential gel electrophoresis facilitate the differential diagnoses of scrapie | Q27319880 | ||
| Multiple sclerosis | Q28214785 | ||
| Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues | Q28253419 | ||
| The genetics of autism | Q28259677 | ||
| Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association | Q28260139 | ||
| Stroke | Q28279570 | ||
| Neuroendocrine tumors of the gastro-entero-pancreatic system | Q28294432 | ||
| Urinary proteomics to support diagnosis of stroke | Q28483776 | ||
| Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics | Q28564214 | ||
| Parkinson's disease. First of two parts | Q29620416 | ||
| Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective | Q30581772 | ||
| Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern | Q33333888 | ||
| Metabonomic evaluation of melamine-induced acute renal toxicity in rats | Q33454866 | ||
| Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors | Q33695494 | ||
| Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 | ||
| Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia | Q34112421 | ||
| Major depressive disorder | Q34122147 | ||
| The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. | Q34280578 | ||
| Identification of organic acids as potential biomarkers in the urine of autistic children using gas chromatography/mass spectrometry. | Q34406490 | ||
| Molecular biology of prion diseases | Q34534878 | ||
| Factors affecting the accuracy of urine-based biomarkers of BSE | Q34607655 | ||
| Sex-specific urinary biomarkers for diagnosing bipolar disorder | Q34757521 | ||
| Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis | Q34974714 | ||
| Urinary peptidomics identifies potential biomarkers for major depressive disorder | Q35128953 | ||
| Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? | Q35212537 | ||
| Effects of three commonly-used diuretics on the urinary proteome. | Q35543587 | ||
| Potential metabolite markers of schizophrenia. | Q36479055 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome | Q36525859 | ||
| NMR-based metabolomics of urine in a mouse model of Alzheimer's disease: identification of oxidative stress biomarkers | Q36670812 | ||
| Urine proteomics to detect biomarkers for chronic allograft dysfunction. | Q37086665 | ||
| Potential serum biomarkers in the pathophysiological processes of stroke | Q37612222 | ||
| Post-acute brain injury urinary signature: a new resource for molecular diagnostics | Q37667700 | ||
| Urinary proteomics--a tool for biomarker discovery | Q37701845 | ||
| Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. | Q37733240 | ||
| Urinary proteomics in cardiovascular disease: Achievements, limits and hopes | Q37869464 | ||
| Rethinking the psychogenic model of complex regional pain syndrome: somatoform disorders and complex regional pain syndrome | Q38162212 | ||
| Proteomic urinary biomarker approach in renal disease: from discovery to implementation | Q38196316 | ||
| Physiological conditions can be reflected in human urine proteome and metabolome | Q38608509 | ||
| Urinary proteomics for prediction of preeclampsia | Q39797354 | ||
| Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls | Q43119044 | ||
| Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. | Q43228011 | ||
| Effects of cigarette smoking on the human urinary proteome | Q43823890 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Neuroscience: Alzheimer's disease | Q44519120 | ||
| Urine-an untapped goldmine for biomarker discovery? | Q46618905 | ||
| LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease. | Q46831696 | ||
| Sex dependence of brain size and shape in bipolar disorder: an exploratory study. | Q47427519 | ||
| Urinary proteomics in obstructive sleep apnoea and obesity. | Q48026870 | ||
| Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease | Q48172055 | ||
| Proteomics urine analysis of pregnant women suffering from multiple sclerosis | Q48270491 | ||
| Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone. | Q48439130 | ||
| The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings. | Q50303972 | ||
| Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. | Q50305558 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| encephalopathy | Q576349 | ||
| biomarker | Q864574 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 345-54 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Genomics Proteomics and Bioinformatics | Q15814350 |
| P1476 | title | Urinary Biomarkers of Brain Diseases | |
| P478 | volume | 13 |
| Q89144244 | Alterations in neuronal metabolism contribute to the pathogenesis of prion disease |
| Q47215035 | Collection and preservation of urinary proteins, using a fluff pulp diaper |
| Q90337843 | Detection of Taenia solium DNA in the Urine of Neurocysticercosis Patients |
| Q57792524 | Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder |
| Q92030166 | Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model |
| Q36219880 | Metabolomics Identifies Multiple Candidate Biomarkers to Diagnose and Stage Human African Trypanosomiasis |
| Q94560655 | Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis |
| Q89218801 | Pre-Analytical Handling Conditions and Small RNA Recovery from Urine for miRNA Profiling |
| Q58591209 | Predictive Role of Urinary Metabolic Profile for Abnormal MRI Score in Preterm Neonates |
| Q33603691 | Proof-of-Concept Workflow for Establishing Reference Intervals of Human Urine Proteome for Monitoring Physiological and Pathological Changes |
| Q36177915 | Quantitative in vivo neurochemical profiling in humans: where are we now? |
| Q88983835 | Salivary biomarkers for the diagnosis and monitoring of neurological diseases |
| Q91973058 | Urinary Amine and Organic Acid Metabolites Evaluated as Markers for Childhood Aggression: The ACTION Biomarker Study |
| Q99406301 | Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics |
Search more.